Medtronic (NYSE: MDT) is recalling 22,110 Cobalt and Crome implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) in the U.S. The Class I recall — the most serious classification from the FDA — is due to the potential for reduced shock energy during high-voltage therapy for Cobalt and Crome ICDs and CRT-Ds, according […]
Medtronic
The 10 largest orthopedic device companies in the world
Stryker, Johnson & Johnson’s DePuy Synthes and Zimmer Biomet are the largest orthopedic device companies. With elective procedure numbers rebounding after the darkest days of the COVID-19 pandemic, sales at most of the world’s largest orthopedic device companies increased by double-digit percentages during their most recent fiscal years. Here are the world’s 10 largest orthopedic […]
How Medtronic aims to address health inequities in diabetes
Fueled by personal experience, Maribel Baker leads Medtronic’s diabetes business toward improving health equity. At 15 years old, Maribel Baker’s life was in the balance. While growing up in Panama, Baker had to undergo leg surgery because she was born with one leg shorter than the other. Following the surgery, she learned that she had […]
6 drug delivery innovations you need to know
From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops. Vaccines, life-saving therapeutics, vision-correcting drugs and more are being developed and marketed for delivery with all kinds of technologies. More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With some […]
The biggest medtech personnel moves so far in 2022
In the ever-changing world of medtech, those who are leading the companies are bound to move around a bit. At the end of last year, we compiled a list of medtech’s biggest personnel changes in 2021. So far in 2022, we’ve already seen a slew of major moves involving some of the space’s most powerful […]
Medtronic, ASGE to expand colon screening program for underserved communities
Medtronic (NYSE:MDT) and the American Society for Gastrointestinal Endoscopy (ASGE) today announced a program expansion. With support from Amazon Web Services’ (AWS) Health Equity Initiative, Medtronic and ASGE are expanding the Medtronic Health Equity Assistance Program for colon cancer screening in medically underserved communities across the U.S., increasing GI Genius units (provided as part of […]
Report: Medtronic to add 200 jobs in Galway
Medtronic (NYSE:MDT) will reportedly be adding 200 research and development positions in Galway, Ireland. According to a report in The Independent, the medtech giant has already filled more than half of the R&D roles, which come as part of a $30 million investment. “These roles will support the development of products and services in the coronary […]
FDA clears Medtronic’s next-gen UNiD spine analyzer
Medtronic (NYSE:MDT) announced today that it received FDA 510(k) clearance for its UNiD spine analyzer v4.0 planning platform. The UNiD spine analyzer v4.0 includes a new Degen algorithm for degenerative spine procedures. The algorithm is designed to leverage machine learning to help surgeons plan and personalize procedures for patients undergoing lower lumbar spine surgery and […]
Medtronic warns on some Cobalt and Crome ICDs
Medtronic (NYSE:MDT) issued an urgent field safety notice in Europe to warn of issues with some implantable cardioverter defibrillators (ICDs). The medtech giant warned healthcare professionals that there is the potential for reduced shock energy — around 79% of programmed energy — during high-voltage (HV) therapy for all Cobalt and Crome ICDs and cardiac resynchronization […]
Medtronic partners with CathWorks with option to acquire down the line
Medtronic (NYSE:MDT) announced today that it entered into a strategic partnership with coronary artery disease (CAD) technology developer CathWorks. Under the agreement, Medtronic will invest up to $75 million and immediately begin co-promotion for CathWorks’ FFRangio system in the U.S. Europe and Japan, where it is commercially available. A separate agreement offers Medtronic the option […]
Former Mazor VP accused of insider trading around Medtronic acquisition
A former Mazor Robotics VP is among three businessmen facing federal insider trading charges and an SEC lawsuit over stock trades leading up to Medtronic’s $1.6 billion acquisition announcement in 2018. Ron Tavlin was Mazor’s VP of business development from 2017 to 2019. Before that, he’d been a paid consultant for Medtronic. The U.S. Attorney’s […]
